Therapeutic Asset Ratings

8,586 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Pyrotinib HER2-expressing Advanced Solid Tumors	Jiangsu HengRui Medicine Co., Ltd.	P1/2	B (60)
Sargramostim Adenocarcinoma of the Pancreas	Barbara Ann Karmanos Cancer Institute	P1/2	B (60)
Sargramostim Recurrent Pancreatic Cancer	Barbara Ann Karmanos Cancer Institute	P1/2	B (60)
Sargramostim Stage III Pancreatic Cancer	Barbara Ann Karmanos Cancer Institute	P1/2	B (60)
Tazemetostat Diffuse Large B Cell Lymphoma	Weill Medical College of Cornell University	P1/2	B (60)
Temsirolimus Solid Tumors	Miller Children's & Women's Hospital Long Beach	P1/2	B (60)
Abexinostat Lymphoma, Non-Hodgkin	Xynomic Pharmaceuticals, Inc.	P1/2	B (59)
Azacitidine Adult Acute Megakaryoblastic Leukemia (M7)	University of Chicago	P1/2	B (59)
Azacitidine Primary Myelofibrosis	M.D. Anderson Cancer Center	P1/2	B (59)
Carboplatin Advanced Solid Tumours	RemeGen Co., Ltd.	P1/2	B (59)
Cediranib HIV Infection	City of Hope Medical Center	P1/2	B (59)
Ciforadenant Renal Cell Cancer	M.D. Anderson Cancer Center	P1/2	B (59)
DARATUMUMAB Non Hodgkin Lymphoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	B (59)
DPC-A69448 Hemophilia A With Inhibitor	Hangzhou Gensciences Biopharmaceutical Co., Ltd.	P1/2	B (59)
Durvalumab CTCL	University of Michigan Rogel Cancer Center	P1/2	B (59)
dzd8586 Lymphoma, Non-Hodgkin	Dizal Pharmaceuticals	P1/2	B (59)
ERIBULIN MONOMETHANESULFONATE Cancer	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P1/2	B (59)
Fludarabine HER2+ Advanced Breast Cancer	National University Hospital, Singapore	P1/2	B (59)
gc101 Tumor Infiltrating Lymphocytes	Shanghai Juncell Therapeutics	P1/2	B (59)
Irinotecan Recurrent Malignant Solid Neoplasm	Children's Oncology Group	P1/2	B (59)
Sargramostim Locally Advanced Pancreatic Adenocarcinoma	Barbara Ann Karmanos Cancer Institute	P1/2	B (59)
Tas-102 MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients	Shanghai EpimAb Biotherapeutics Co., Ltd.	P1/2	B (59)
trc102 Neoplasm	National Cancer Institute (NCI)	P1/2	B (59)
Veliparib Solid Tumors	National Cancer Institute (NCI)	P1/2	B (59)
anv419 Adult Disease	Anaveon AG	P1/2	B (58)

Showing 51 to 75 of 8,586 assets

PreviousPage 3 of 344Next